AU6589200A - Extended release formulation of etodolac - Google Patents
Extended release formulation of etodolacInfo
- Publication number
- AU6589200A AU6589200A AU65892/00A AU6589200A AU6589200A AU 6589200 A AU6589200 A AU 6589200A AU 65892/00 A AU65892/00 A AU 65892/00A AU 6589200 A AU6589200 A AU 6589200A AU 6589200 A AU6589200 A AU 6589200A
- Authority
- AU
- Australia
- Prior art keywords
- etodolac
- release formulation
- extended release
- formulation
- extended
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1210/DEL/99 | 1999-09-10 | ||
IN1210DE1999 IN190974B (zh) | 1999-09-10 | 1999-09-10 | |
US09/648,949 US6586005B1 (en) | 1999-09-10 | 2000-08-25 | Extended release formulation of etodolac |
US09648949 | 2000-08-25 | ||
PCT/IB2000/001208 WO2001019349A2 (en) | 1999-09-10 | 2000-08-30 | Extended release formulation of etodolac |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6589200A true AU6589200A (en) | 2001-04-17 |
Family
ID=26324703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU65892/00A Abandoned AU6589200A (en) | 1999-09-10 | 2000-08-30 | Extended release formulation of etodolac |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1227001C (zh) |
AU (1) | AU6589200A (zh) |
WO (1) | WO2001019349A2 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0206505D0 (en) * | 2002-03-19 | 2002-05-01 | Euro Celtique Sa | Pharmaceutical combination |
EA200401334A1 (ru) * | 2002-04-11 | 2005-04-28 | Ранбакси Лабораторис Лимитед | Фармацевтические композиции карбидопы и леводопы с контролируемым высвобождением |
WO2007004425A1 (ja) * | 2005-06-22 | 2007-01-11 | Takeda Pharmaceutical Company Limited | 難溶性の有効成分を含有する錠剤 |
JP5208729B2 (ja) | 2006-04-12 | 2013-06-12 | 日本曹達株式会社 | 徐放性錠剤の製造方法 |
CN101259113B (zh) * | 2008-04-21 | 2013-02-13 | 沈阳药科大学 | 依托度酸渗透泵型控释制剂 |
TR200908308A1 (tr) | 2010-01-18 | 2011-08-22 | Turgut İlaçlari A.Ş. | Etodolak içeren sürekli salım tablet formulasyonu |
CN102485215B (zh) * | 2010-12-03 | 2013-05-15 | 沈阳药科大学 | 依托度酸定时释药微丸制剂及其制备方法 |
GB201420306D0 (en) | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Compositions |
CN106727390A (zh) * | 2015-11-19 | 2017-05-31 | 哈尔滨圣吉药业股份有限公司 | 一种依托度酸缓释片及其制备方法 |
CN114699380A (zh) * | 2021-12-27 | 2022-07-05 | 南京联智医药科技有限公司 | 一种依托度酸片及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK74396A3 (en) * | 1995-06-13 | 1997-04-09 | American Home Prod | Organoleptically acceptable oral pharmaceutical compositions |
US6251430B1 (en) * | 1998-02-04 | 2001-06-26 | Guohua Zhang | Water insoluble polymer based sustained release formulation |
US6106862A (en) * | 1998-08-13 | 2000-08-22 | Andrx Corporation | Once daily analgesic tablet |
-
2000
- 2000-08-30 WO PCT/IB2000/001208 patent/WO2001019349A2/en active Application Filing
- 2000-08-30 CN CNB008143196A patent/CN1227001C/zh not_active Expired - Fee Related
- 2000-08-30 AU AU65892/00A patent/AU6589200A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1402631A (zh) | 2003-03-12 |
WO2001019349A2 (en) | 2001-03-22 |
CN1227001C (zh) | 2005-11-16 |
WO2001019349A3 (en) | 2001-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3867400A (en) | Methods of using bioelastomers | |
AUPP970099A0 (en) | Concrete formulation | |
AU6314900A (en) | Biarylurea derivatives | |
HUP0203680A3 (en) | Controlled release hydrocodone formulations | |
AU6714700A (en) | Cyclopropylindole derivatives | |
AU1278701A (en) | Novel compounds | |
AU4458700A (en) | Uses of phenylglycine derivatives | |
AU2557500A (en) | Methods of making compounds | |
AU4213299A (en) | Controlled release of substances | |
AU5429000A (en) | Novel bicyclonucleoside derivatives | |
AU6564600A (en) | Copolymers of acryloyloxyalkylamino compounds | |
AU3670000A (en) | Novel thiazolobenzimidazole derivatives | |
AU6510400A (en) | Slow release microspheres | |
AU7952800A (en) | 2-alkoxybenzene derivatives | |
AU2001232948A1 (en) | Controlled release of drugs | |
AU6589200A (en) | Extended release formulation of etodolac | |
AU6690300A (en) | Copolymers of acryloylaminoalkyl compounds | |
AU2982000A (en) | Preparation of 9-hydrocarbyl-9-phosphabicyclononanes | |
AU5433699A (en) | Spacing of tiles | |
AU3775500A (en) | Setting of gemstones | |
AU2829700A (en) | Processes for the preparation of alpha-aminoketones | |
AU1601801A (en) | Methods of preparing crna | |
AU4081300A (en) | Centroid integration | |
AU7711800A (en) | Novel uses of 2-bromopalmitate | |
AU2109700A (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |